Intermedilysin, a novel cytotoxin specific for human cells, secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess

Infection and Immunity

Volumn 64, Issue 8, 1996, Pages 3093-3100

  Nagamune, Hideaki ^a   Ohnishi, Chikako ^a   Katsuura, Ayako ^a   Fushitani, Kenzo ^b   Whiley, Robert A ^c   Tsuji, Akihiko ^a   Matsuda, Yoshiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOLYSIN; CYTOTOXIN; INTERMEDILYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; LIVER ABSCESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MILLERI; TOXIN ANALYSIS;

EID: 0030037295     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.8.3093-3100.1996     Document Type: Article

References (48)

1. Alouf, J. E. 1976. Cell membranes and cytolytic bacterial toxins, p. 220-270. In P. Cuatrecasas (ed.), The specificity and action of animal, bacterial and plant toxins, receptors and recognition series B, vol. 1. Chapman & Hall, London.
2. Arala-Chaves, M. P., T. B. Higerd, M. T. Porto, J. Munoz, J.-M. Goust, H. H. Fudenberg, and C. B. Loadholt. 1979. Evidence for the synthesis and release of strongly immunosuppressive, noncytotoxic substances by Streptococcus intermedius. J. Clin. Invest. 64:871-883.
3. Bateman, N. T., S. J. Eykyn, and I. Phillips. 1975. Pyogenic liver abscess caused by Streptococcus milleri. Lancet i:657-659.
4. Beighton, D., and R. A. Whiley. 1990. Sialidase activity of the "Streptococcus milleri group" and other viridans group streptococci. J. Clin. Microbiol. 28:1431-1433.
5. Braun, V., and T. Focareta. 1991. Pore-forming bacterial protein hemolysins (cytolysins). Crit. Rev. Microbiol. 18:115-158.
6. Brook, I., and E. H. Frazier. 1994. Microacrophilic streptococci as a significant pathogen: a twelve-year review. J. Med. 25:129-144.
7. Cabiaux, V., P. Lorge, M. Vandenbranden, P. Falmagne, and J. M. Ruysschaert. 1985. Tetanus toxin induces fusion and aggregation of lipid vesicles containing phosphatidylinositol at low pH. Biochem. Biophys. Res. Commun. 128:840-849.
8. Chua, D., H. H. Reinhart, and J. D. Sobel. 1989. Liver abscess caused by Streptococcus milleri. Rev. Infect. Dis. 11:197-202.
9. De Louvois, J. 1980. Bacteriological examination of pus from abscesses of the central nervous system. J. Clin. Pathol. 33:66-71.
10. Geoffroy, C., and J. E. Alouf. 1983. Selective purification by thiol-disulfide interchange chromatography of alveolysin, a sulfhydryl-activated toxin of Bacillus alvei. J. Biol. Chem. 258:9968-9972.
11. Geoffroy, C., J. Mengaud, J. E. Alouf, and P. Cossart. 1990. Alveolysin, the thiol-activated toxin of Bacillus alvei, is homologous to listeriolysin O, perfringolysin O, pneumolysin, and streptolysin O and contains a single cysteine. J. Bacteriol. 172:7301-7305.
12. Gossling, J. 1988. Occurrence and pathogenicity of the Streptococcus milleri group. Rev. Infect. Dis. 10:257-285.
13. Homer, K. A., M. C. Grootveld, J. Hawkes, D. P. Naughton, and D. Beighton. 1994. Degradation of hyaluronate by Streptococcus intermedius strain UNS35. J. Med. Microbiol. 41:414-422.
14. Homer, K. A., R. A. Whiley, and D. Beighton. 1994. Production of specific glycosidase activities by Streptococcus intermedius strain UNS35 grown in the presence of mucin. J. Med. Microbiol. 41:184-190.
15. Iwamoto, M., Y. Ohno-Iwashita, and S. Ando. 1987. Role of the essential thiol group in the thiol-activated cytolysin from Clostridium perfringens. Eur. J. Biochem. 167:425-430.
16. Jacobs, A. A. C., P. L. W. Loeffen, A. J. G. Van den Berg, and P. K. Storm. 1994. Identification, purification, and characterization of a thiol-activated hemolysin (Suilysin) of Streptococcus suis. Infect. Immun. 62:1742-1748.
17. Johnson, M. K. 1972. Properties of purified pneumonococcal hemolysin. Infect. Immun. 6:755-760.
18. Kehoe, M. A., L. Miller, J. A. Walker, and G. J. Boulnois. 1987. Nucleotide sequence of the streptolysin O (SLO) gene: structural homologies between SLO and other membrane-damaging, thiol-activated toxins. Infect. Immun. 55:3228-3232.
19. Koepke, J. A. 1965. Meningitis due to Streptococcus anginosus (Lancefield group F). JAMA 193:739-740.
20. Kyhse-Andersen, J. 1984. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J. Biochem. Biophys. Methods 10:203-209.
21. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
22. Lütticken, R., U. Wendorff, D. Lütticken, E. A. Johnson, and L. W. Wannamaker. 1978. Studies on streptococci resembling Streptococcus milleri and on an associated surface-protein antigen. J. Med. Microbiol. 11:419-431.
23. Mengaud, J., M.-F. Vicente, J. Chenevert, J. M. Pereira, C. Geoffroy, B. Gicquel-Sanzey, F. Baquero, J.-C. Perez-Diaz, and P. Cossart. 1988. Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infect. Immun. 56:766-772.
24. Morgan, P. J., S. C. Hyman, O. Byron, P. W. Andrew, T. J. Mitchell, and A. J. Rowe. 1994. Modeling the bacterial protein toxin, pneumolysin, in its monomeric and oligomeric form. J. Biol. Chem. 269:25315-25320.
25. 24a.Nagamune, H., et al. Unpublished observations.
26. Nagamune, H., K. Muramatsu, T. Akamatsu, Y. Tamai, K. Izumi, A. Tsuji, and Y. Matsuda. 1995. Distribution of the Kexin family proteases in pancreatic islets: PACE4C is specifically expressed in B cells of pancreatic islets. Endocrinol. 136:357-360.
27. Ottens, H., and K. C. Winkler. 1962. Indifferent and haemolytic streptococci possessing group-antigen F. J. Gen. Microbiol. 28:181-191.
28. Parker, M. T., and L. C. Ball. 1976. Streptococci and aerococci associated with systemic infection in man. J. Med. Microbiol. 9:275-302.
29. Poole, P. M., and G. Wilson. 1977. Streptococcus milleri in the appendix. J. Clin. Pathol. 30:937-942.
30. Posnett, D. N., H. McGrath, and J. P. Tam. 1988. A novel method for producing anti-peptide antibodies. J. Biol. Chem. 263:1719-1725.
31. Ruoff, K. L. 1988. Streptococcus anginosus ("Streptococcus milleri"). Clin. Microbiol. Newsl. 10:65-68.
32. Ruoff, K. L. 1988. Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen. Clin. Microbiol. Rev. 1:102-108.
33. Saitou, N., and S. Ueda. 1994. Evolutionary rates of insertion and deletion in noncoding nucleotide sequences of primates. Mol. Biol. Evol. 11:504-512.
34. Singh, K. P., A. Morris, S. D. R. Lang, D. M. MacCulloch, and D. A. Bremner. 1988. Clinically significant Streptococcus anginosus (Streptococcus milleri) infections: a review of 186 cases. N. Z. Med. J. 101:813-816.
35. Smyth, C. J., and J. L. Duncan. 1978. Thiol-activated (oxygen-labile) cytolysins, p. 129-183 In 3. Jeljaszewicz and T. Wadstrom (ed.), Bacterial toxins and cell membranes. Academic Press, London.
36. Taketoshi, M., K. Kitada, T. Yakushiji, and M. Inoue. 1993. Enzymatic differentiation and biochemical and serological characteristics of the clinical isolates of Streptococcus anginosus, S. intermedius and S. constellatus, Microbios 76:115-129.
37. Terleckyj, B., N. P. Willett, and G. D. Shockman. 1975. Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect. Immun. 11:649-655.
38. Tweten, R. K. 1988. Nucleotide sequence of the gene for perfringolysin O (theta-toxin) from Clostridium perfringens: significant homology with genes for streptolysin O and pneumolysin. Infect. Immun. 56:3235-3240.
39. Van der Auwera, P. 1985. Clinical significance of Streptococcus milleri. Eur. J. Clin. Microbiol. 4:386-390.
40. Van Epps, D. E., and B. R. Andersen. 1971. Streptolysin O. II. Relationship of sulfhydryl groups to activity. Infect. Immun. 3:648-652.
41. Walker, J. A., R. L. Allen, P. Falmagne, M. K. Johnson, and G. J. Boulnois. 1987. Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect. Immun. 55:1184-1189.
42. Whiley, R. A., and D. Beighton. 1991. Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species. Int. J. Syst. Bacteriol. 41:1-5.
43. Whiley, R. A., D. Beighton, T. G. Winstanley, H. Y. Fraser, and J. M. Hardie. 1992. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J. Clin. Microbiol. 30:243-244.
44. Whiley, R. A., H. Fraser, J. M. Hardie, and D. Beighton. 1990. Phenotypic differentiation of Streptococcus intermedius. Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group." J. Clin. Microbiol. 28:1497-1501.
45. Whiley, R. A., and J. M. Hardie. 1989. DNA-DNA hybridization studies and phenotypic characteristics of strains within the 'Streptococcus milleri group.' J. Gen. Microbiol. 135:2623-2633.
46. Willcox, M. D. P., M. Patrikakis, C. Y. Loo, and K. W. Knox. 1993. Albumin-binding proteins on the surface of the Streptococcus milleri group and characterization of the albumin receptor of Streptococcus intermedius C5. J. Gen. Microbiol. 139:2451-2458.
47. Wisnieski, B. J., and J. S. Bramhall. 1981. Photolabelling of cholera toxin subunits during membrane penetration. Nature (London) 289:319-321.
48. Yamaguchi, T., M. Taketoshi, H. Eifuku-Koreeda, T. Yakushiji, and M. Inoue. 1993. Haemagglutinating activities of oral strains of Streptococcus milleri group. Microbios 75:249-259.